We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 28, 2022

Effect of Levofloxacin on the Efficacy and Adverse Events Associated With Intravesical BCG Treatment for Bladder Cancer

European Urology Focus


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology Focus
Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study
Eur Urol Focus 2022 Jun 15;[EPub Ahead of Print], K Numakura, M Kobayashi, T Ishida, K Okane, K Suzuki, N Shimoda, T Suzuki, T Kumazawa, R Sasaki, H Fukuda, S Kashima, R Yamamoto, A Koizumi, T Nara, S Kanda, M Huang, M Saito, S Narita, T Inoue, N Tsuchiya, T Habuchi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading